Casma Therapeutics' Series A Round

Casma Therapeutics raised a round of funding on May 03, 2018. Investors include Third Rock Ventures.

Casma Therapeutics is harnessing the natural cellular process of autophagy to design new medicines for a broad range of diseases.…

Articles about Casma Therapeutics' Series A Round: